New Painkiller Could be Bigger than Oxycodone

I never understood addiction until I had a small surgery about 15 years ago. It was minor, but involved some pain.

While I lay on the table, the anesthesiologist gave me a slow drip of a morphine derivative mixed with Valium over about an hour, while doctors worked on me.

During that time I didn’t have a care in the world. Had World War III broken out, I wouldn’t have cared. If someone had come in with a knife to cut my throat, I would’ve smiled at him.

When I came out of it, I understood addiction for the first time in my life, I understood that someone would want to go back to that place. And that’s the worrisome part.

At some point in your life, you are likely to be injected with a highly addictive drug. When that happens, you will have to make a choice between continuing to take that drug and living in unbearable pain.

It’s not a choice, really. Unbearable pain is… unbearable.

It might be that you’ll have major surgery or be in a car crash. Maybe you’ll fall and break a hip. But at some point, you’ll have to deal with serious pain, and the only choice medical science can offer you is a morphine derivative, or morphine itself.

Unfortunately, that’s a bit like taking heroin under a doctor’s care.

I only had a drug like that once, but once was enough to understand the power of opiates.

It also made me afraid of taking any painkillers unless I really need them.

The experience even made me cautious about everyday painkillers like Tylenol and aspirin and ibuprofen, which have far more dangerous side effects than most people think, yet remain relatively nonaddictive.

Still, anyone who knows someone with arthritis knows people who are essentially addicted to drugs like ibuprofen, although not for euphoric feelings.

A Surprising Solution to the Morphine Addiction Problem 

For years, I though we might have to give up on treating unbearable pain without opiates.

But for the past decade, one small company has been testing a revolutionary new pain drug that’s about to go into FDA Phase 3 trials.

It works like morphine, but doesn’t have serious side effects.

If the company is successful, and I believe it will be, it’ll help tens of millions who would otherwise struggle to break an addiction to their pain medication.

This is revolutionary in the medical world.

It’s one of the most exciting ideas I’ve seen since becoming editor of Breakthrough Technology Alert.

It could replace 5.5 million Oxycodone prescriptions and be the painkiller of choice in 40 million surgical procedures happening in the U.S. each year.

I’ve followed this technology for year. Unfortunately, it was for private investors only.

But that all changed in January when the company went public.

It’s a smart move, if you ask me.

I consider it the potential Microsoft of the pain management industry.

Bill Gates invented MS-DOS to address a simple but obvious problem — no one who wasn’t a trained programmer could operate a computer.

His single idea turned a garage startup into the third most profitable business in the United States in 2013.

One hundred shares of Microsoft would have sold for $1.4 million at the height of its share price in 1999.

Steve Jobs at Apple changed the way we communicate forever by taking clunky, cumbersome smartphones and giving them the ability to process almost unlimited applications.

A $5,000 investment in Apple at its IPO would be worth close to $1,304,530 today.

A nonaddictive pain medication addresses an obvious but maddening problem, just as MS-DOS and the iPhone took on roadblocks everyone despised.

It’s rare to find an early Microsoft or Apple, so to speak — a company with life-altering technology.

But when we do, we want to jump in with both feet.


Stephen Petranek

You May Also Be Interested In:

Bargain Hunters Buy Tech – Try the Dover Sole

So Technology appeared to open its eyes yesterday as investors went on a shopping spree – looking for bargains across the industry – after some tech names got absolutely clobbered on Monday and Tuesday after PFE’s blockbuster vaccine announcement… conversely – the winners of late – including Energy, Financials, and Industrials took a breather…

Stephen Petranek

Stephen Petranek’s career of over 40 years in the publishing world is marked by numerous prizes and awards for excellent writing on science, nature, technology, politics, economics and more. He has been editor-in-chief of the Miami Herald’s prestigious Sunday magazine, Tropic, and has covered a wide range of topics for Time Inc.’s Life magazine. His...

View More By Stephen Petranek